|
Status |
Public on Feb 28, 2017 |
Title |
Pentraxin-3 is a PI 3-Kinase Effector that Regulates Stem-Cell-Like Traits in Basal-Like Breast Cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
MCF10A cells: control vs. PIK3CA mutant (H1047R) Transcriptional profiling of MCF10A comparing control (expressing JP1520-PIK3CA-WT; Addgen plasmid #14570) and PIK3CA mutant (JP1520-PIK3CA-H1047R; Addgene plasmic#14572). Goal was to determine the effects of the PIK3CA H1047R mutation in the on global gene expression in MCF10A cells.
|
|
|
Overall design |
Two-condition experiment, ES vs. TF-ES cells. Biological replicates: 4 control replicates, 3 transfected replicates.
|
|
|
Contributor(s) |
Henry W, Toker A, Karnoub A |
Citation(s) |
28223411 |
|
Submission date |
Jan 11, 2017 |
Last update date |
Apr 23, 2018 |
Contact name |
Antoine Elias Karnoub |
E-mail(s) |
akarnoub@bidmc.harvard.edu
|
Phone |
617-735-2082
|
Organization name |
Beth Israel Deaconess Medical Center and Harvard Medical School
|
Department |
Pathology
|
Lab |
Karnoub Lab
|
Street address |
3 Blackfan Circle
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02215 |
Country |
USA |
|
|
Platforms (1) |
GPL16699 |
Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Feature Number version) |
|
Samples (3) |
|
Relations |
BioProject |
PRJNA360951 |